Category: Medmonitor

May 20, 2024
Rezenopy Approved for Treatment of Opioid Overdose

A new naloxone nasal spray will soon be available.

READ MORE
April 24, 2024
Lot of Methocarbamol Recalled Due to White Particles

Patients taking this muscle relaxant may be impacted by a lot from Eugia US/AuroMedics Pharma.

READ MORE
April 23, 2024
Cardiovascular Drug Approvals

As firefighters see more presumptions for heart disease, keeping track of heart medications could grow in importance.

READ MORE
March 21, 2024
New Autoimmune Biosimilar Approved and Alzheimer’s Drug Goes Generic

Simlandi injection was approved for arthritic conditions, while Namzaric receives its first generic approval.

READ MORE
February 21, 2024
FDA Evaluates Report of Suicidal Thoughts with GLP-1 Inhibitors

While no clear link is established to these obesity and diabetes drugs, the FDA will continue to monitor data.

READ MORE
January 17, 2024
FDA Issues Respective Warnings for Compounded and Counterfeit Semaglutide

The growing demand for this drug has led individuals to search for semaglutide from alternative sources.

READ MORE
December 14, 2023
FDA Warns of Rare Drug Interactions with Antiseizure Drugs

Hypersensitivity reactions may start as a rash but can quickly result in injury to internal organs.

READ MORE
November 16, 2023
FDA Approves New Formulation of Combogesic

The acetaminophen and ibuprofen combination was approved for IV use, and as an adjunct to opioid therapy for the treatment of pain.

READ MORE
October 19, 2023
New Depression Product and Diabetes Generic Approvals

Exuua was approved for major depressive disorder, while two diabetes medications receive generic approvals.

READ MORE
August 24, 2023
Tornado Damages Pfizer Pharmaceutical Plant, Drug Shortages May Follow

As other Pfizer plants shift gears to make up for this damage, overall drug manufacturing may slow in some areas.

READ MORE
1 2 3 8
lockenvelopephone-handsetmagnifiermenucross-circle